Lilly To Sell Intramuscular Zyproxa From December, First Atypical Antipsychotic In Japan
This article was originally published in PharmAsia News
Executive Summary
Eli Lilly launched Zyproxa (olanzapine), a fast-acting intramuscular preparation used in the acute treatment of schizophrenia Dec. 3.